What is ALT's current stock price?

As of now, ALT is trading at $5.60, with a daily change of +9.80%.

What are the risks associated with ALT stock?

ALT has Fair, risk level based on volatility, sector strength, volume, investor confidence and outlook.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ALT Stock Analysis & IQ Rating | Altimmune

ALT

Altimmune

$5.60

+$0.50 | +9.80%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$7.73

MKT CAP

$631.87M

52W Low

$2.91

VOL

$6.20M

P/E Ratio

N/A

AVG VOL

$6.27M

RSI

62.13

TREND

Sideways

ALT Stock IQ

Login to see Altimmune (ALT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ALT Target Price

Login to display

Strengths

ALT Rewards

Earnings are forecast to grow

ALT Rewards

Upgraded on attractively valued

ALT Rewards

Outperform the market

ALT Price Performance

$4.09 (+36.92%)

$3.77 (+48.54%)

$3.78 (+48.15%)

$6.48 (-13.58%)

1year

6month

3month

1month

ALT Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

ALT Analysts Opinion

ALT Analysts opinion is negative and it remained unchanged from the past 3 months

ALT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

57%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

NA

ALT Street Sentiment

ALT Street Sentiment is bullish and have negative views on the near-term outlook

ALT Risk Level

ALT has Fair risk level

Risks Indicators

Price under $5

High volatilty

Fair

LOW

HIGH

ALT Performance Sentiment

Sentiments overview associated with events and the stock performance

57%

43%

Positive

Negative

13 out of 23
events present

10 out of 23
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$5.12

Resistance
Price

$3.51

Current Price Range

$6.18

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

2

0

Date

Action

Rating

Firm

Nov 08, 2025

Reiterate

Outperform

Citizens

Oct 20, 2025

Reiterate

Buy

HC Wainwright & Co.

Oct 10, 2025

Reiterate

Buy

HC Wainwright & Co.

Linked to ALT

Close Price

Change

VKTX

Viking Therapeutics

29.04

-3.97%

Recently Viewed

Close Price

Change

ALT

Altimmune

5.60

+9.80%

TXN

Texas Instrument

215.55

-0.92%

RYAAY

Ryanair

70.60

+0.16%

LI

Li Auto

16.63

-3.65%

APTV

Aptiv

75.75

-3.91%

ALT Latest Analysis +

Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock. GAITHERSBURG Md. Jan. 29 2026 (GLOBE NEWSWIRE) -- Altimmune Inc. (Nasdaq: ALT) a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17045454 shares of its common sto

Thu Jan 29, 2026

$5.10 | -0.39%

Activity

Altimmune (ALT) Shares Slide On $75 Million Stock Offering. ALT) shares are tumbling on Wednesday following the company’.s announcement of a $75 million registered direct offering of common stock. Here’.s what investors .The company has entered a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17045454 shares of Altimmune common stock (or pre-funded warrants in lieu thereof). Altimmune said the transaction is expected to generate

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Momentum

Altimmune: Why Breakthrough Status Isnt A Buy Signal Just Yet.

Wed Jan 28, 2026

$5.12 | -17.15%

Technical

Altimmune stock falls after announcing $75 million direct offering.

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Momentum

Altimmune Prices $75 Mln Of Share Offering. Stock Down . (RTTNews) - Altimmune Inc. (ALT) a late clinical-stage biopharmaceutical company said it entered into an agreement with a new fundamental institutional investor for the purchase and sale of 17.05 million common stock or as pre-funded warrants.

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Momentum

Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock. GAITHERSBURG Md. Jan. 27 2026 (GLOBE NEWSWIRE) -- Altimmune Inc. (Nasdaq: ALT) a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases announced today that it has entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17045454 shares of its common stock (or pre-funded warrants in lieu thereof) purs

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

FAQ About ALT Stock Insights

What is ALT current stock price?

What are ALT stock strengths?

What is ALT Risk Level?

What is ALT market cap and volume?

What is ALT current Stock IQ?

Should I buy ALT stock right now?

Is ALT a Strong Buy right now?

What does a 'Strong Buy' rating mean for ALT?

What does a 'Strong Sell' rating mean for ALT?

What factors influence ALT's Stock IQ?

Explore our ALT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ALT Stock Strategies
Effective Risk Management

FIND US ON

Receive our ALT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ALT

Altimmune

Set Alerts

Current Price

$5.60

+$0.50 | +9.80%

52W High

$7.73

MKT CAP

$631.87M

52W Low

$2.91

VOL

$6.20M

P/E Ratio

N/A

AVG VOL

$6.27M

RSI

62.13

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Linked to ALT

Symbol

Close

Change

VKTX

Viking Therapeutics

29.04

-3.97%

ALT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

57%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

NA

ALT Street Sentiment

ALT Street Sentiment is bullish and have negative views on the near-term outlook

ALT Risk Level

ALT has Fair risk level

Risks Indicators

Price under $5

High volatilty

Fair

LOW

HIGH

ALT Performance Sentiment

Sentiments overview associated with events and the stock performance.

57%

43%

Positive

Negative

13 out of 23
events present

10 out of 23
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support
Price

$5.12

Resistance
Price

$3.51

Current Price Range

$6.18

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Buy

Hold

Sell

Consensus Rating

STRONG BUY

2

0

Date

Action

Rating

Firm

Nov 08, 2025

Reiterate

Outperform

Citizens

Oct 20, 2025

Reiterate

Buy

HC Wainwright & Co.

Oct 10, 2025

Reiterate

Buy

HC Wainwright & Co.

ALT Stock IQ

Login to unlock Altimmune (ALT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

ALT Rewards

Earnings are forecast to grow

ALT Rewards

Upgraded on attractively valued

ALT Rewards

Outperform the market

ALT Latest Analysis

Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock. GAITHERSBURG Md. Jan. 29 2026 (GLOBE NEWSWIRE) -- Altimmune Inc. (Nasdaq: ALT) a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases announced the closing of its previously announced registered direct offering pursuant to a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17045454 shares of its common sto

Thu Jan 29, 2026

$5.10 | -0.39%

Activity

Altimmune (ALT) Shares Slide On $75 Million Stock Offering. ALT) shares are tumbling on Wednesday following the company’.s announcement of a $75 million registered direct offering of common stock. Here’.s what investors .The company has entered a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17045454 shares of Altimmune common stock (or pre-funded warrants in lieu thereof). Altimmune said the transaction is expected to generate

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Momentum

Altimmune: Why Breakthrough Status Isnt A Buy Signal Just Yet.

Wed Jan 28, 2026

$5.12 | -17.15%

Technical

Altimmune stock falls after announcing $75 million direct offering.

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Momentum

Altimmune Prices $75 Mln Of Share Offering. Stock Down . (RTTNews) - Altimmune Inc. (ALT) a late clinical-stage biopharmaceutical company said it entered into an agreement with a new fundamental institutional investor for the purchase and sale of 17.05 million common stock or as pre-funded warrants.

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Momentum

Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock. GAITHERSBURG Md. Jan. 27 2026 (GLOBE NEWSWIRE) -- Altimmune Inc. (Nasdaq: ALT) a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases announced today that it has entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 17045454 shares of its common stock (or pre-funded warrants in lieu thereof) purs

Wed Jan 28, 2026

$5.12 | -17.15%

Activity

Discover ALT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ALT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ALT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ALT Stock trends

ALT Stock performance

ALT Stock analysis

ALT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ALT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ALT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

ALT Stock Analysis & IQ Rating | Altimmune

ALT Stock IQ

ALT Target Price

ALT Analysts Opinion

ALT Street Sentiment

ALT Risk Level

ALT Performance Sentiment

Key Price Levels

Analyst Consensus

Explore our ALT Stock insights

Receive our ALT Daily Alerts

ALT Street Sentiment

ALT Risk Level

Key Price Levels

Latest Analyst Actions

Discover ALT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ALT. We're here to help you make informed investment decisions today.

Receive our ALT Daily Alerts

ALT Alerts